10000122

Organization name

Fidia Farmaceutici S.p.A.

SRN

IT-MF-000026988

Manufacturer status

Active

9 warnings recorded — scroll inside the panel to see all entries.

• CW275

  EUDAMED did not publish a description for this code.
• CW010

  EUDAMED did not publish a description for this code.
• CW009

  EUDAMED did not publish a description for this code.
• CW007

  EUDAMED did not publish a description for this code.
• CW032

  EUDAMED did not publish a description for this code.
• CW135

  EUDAMED did not publish a description for this code.
• CW999

  Hyalotend should not be administered to patients with known hypersensitivity to any component of the product.
• CW999

  Peritendinous injections of Hyalotend are contraindicated in cases of infections or skin diseases in the area of the injection site.
• CW999

  The assembled syringe must be discarded immediately after use, regardless of whether or not the solution has been completely administered. If a syringe is retained for a subsequent injection there is a risk of contamination that could lead to illness, infection and/or serious injury to the patient.

Primary placement in Italy; available across 1 country total.

Trade name

not provided

UDI-DI code

D-100001222G

Basic UDI-DI

B-100001222G

Reference / catalog number

10000122

Issuing entity

EUDAMED

Risk category

Class III

Applicable legislation

MDD [Directive 93/42/EEC on medical devices]

Status

On the market

Quantity

1

Additional product description

—

Additional information URL

No additional information URL provided by the manufacturer.

Clinical sizes

• 20 mg/2 ml

European Medical Device Nomenclature — the EU product classification assigned to this device.

• P900402RESORBABLE FILLING AND RECONSTRUCTION DEVICES